NHL: Fentanyl, cocaine involved in former Bruin Jimmy Hayes’ death

Date:

Share post:


Former NHL forward Jimmy Hayes, who passed away at age 31 in August, had fentanyl and cocaine in his system at the time of his death, family members told the Boston Globe.

Hayes had a seven-year NHL career with the Chicago Blackhawks, Florida Panthers, Boston Bruins and New Jersey Devils. His brother, Kevin Hayes, currently plays for the Philadelphia Flyers.

A Boston area native, Jimmy Hayes also won an NCAA hockey championship with Boston College in 2010.

He was pronounced dead at his home in Milton, Mass., on Aug. 23. A cause of death was not available at that time, but Hayes’ family recently received the toxicology report.

His family remembered Jimmy as a young husband and father who always looked to do good deeds for others.

“I hope getting Jimmy’s story out there can save someone’s life. If this can save someone from the pain, great,” Kevin Hayes told the Globe. “It’s just so sad. I pride myself on being pretty mentally strong. I’m a street guy. But there’s just no formula for this.”

The Devils and Blackhawks held a pregame tribute for Hayes before New Jersey’s season opener Friday.

–Field Level Media

spot_img

Related articles

NHL: Avalanche save crucial penalty shot, hold off Flyers

Mackenzie Blackwood made 23 saves, including one on Trevor Zegras' third-period penalty shot, and the visiting Colorado Avalanche...

NHL: Capitals F Ryan Leonard, G Charlie Lindgren sent to IR

Washington Capitals rookie forward Ryan Leonard and goaltender Charlie Lindgren were placed on injured reserve Sunday with respective...

NHL: Golden Knights eager to add to Rangers’ home-ice woes

While the Las Vegas Golden Knights spent Saturday afternoon at a relaxing skate a few blocks south of...

NHL: Ducks’ Beckett Sennecke bids to stay hot vs. Blackhawks

Intent on breaking free from an up-and-down run of late, the Anaheim Ducks will complete a stretch of...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.